US Broker Ratings

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Valuation Insights Amid Strong Healthcare Sector Performance

Merck & Company, Inc. (NYSE: MRK), a leading player in the healthcare sector, continues to hold significant appeal for investors with its formidable market presence and robust product portfolio. As..

Avantor, Inc. (AVTR) Stock Analysis: Unpacking a 37.78% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.39 billion, Avantor offers..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Unveiling a Potential 19.47% Upside in the Healthcare Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a prominent player in the diagnostics and research industry, is making waves with its potential upside of 19.47%. Headquartered in Greifensee, Switzerland, this healthcare sector..

Medpace Holdings, Inc. (MEDP): Investor Outlook and Key Insights Amidst a Robust Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) is a notable player in the healthcare sector, particularly within the diagnostics and research industry. With its comprehensive suite of clinical research-based services, Medpace supports..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Powerhouse with 35.20% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, stands out with a compelling potential upside of 35.20%, according to the latest analyst ratings. With a market capitalization..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 16.91% Potential Upside Amidst Market Challenges

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector focusing on drug manufacturing, continues to capture investor interest with its dynamic portfolio of therapies and strategic collaborations. While..

Humana Inc. (HUM) Stock Analysis: Exploring a 19.31% Potential Upside in the Healthcare Sector

Humana Inc. (HUM) stands as a formidable player in the healthcare plans industry, a sector known for its resilience and steady demand. With a market capitalization of $21.45 billion, Humana..

Summit Therapeutics (SMMT) Stock Analysis: Exploring a Potential 50% Upside in Biotech Innovation

Investors with an eye on the healthcare sector may find Summit Therapeutics Inc. (NASDAQ: SMMT) an intriguing candidate, given its substantial potential upside and innovative developments in the biotechnology space...

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 13.95% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a cornerstone in the healthcare sector, specializes in medical devices and has a robust foothold in the United Kingdom. With a market capitalization..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Path Ahead with 6.85% Potential Upside

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector’s Diagnostics & Research industry, holds a commanding presence in the genetic and genomic analysis market. Headquartered in San Diego, California,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 32.87% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) has been attracting attention from investors with its significant potential upside of 32.87%. This U.S.-based healthcare giant operates in the medical devices industry and..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 41% Potential Upside with Robust Analyst Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with a striking 41% potential upside. With a market capitalization..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring the 21.84% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a leading provider in the global healthcare sector, occupies an essential niche in the medical care facilities industry. With its headquarters in Bad Homburg,..

Incyte Corporation (INCY) Stock Analysis: Unpacking the 11.68% Potential Upside for Investors

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, currently offers a compelling investment opportunity with a potential upside of 11.68%. Headquartered in Wilmington, Delaware, Incyte is a..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth Opportunities with a 4.23% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the pharmaceutical industry, presents an intriguing proposition for investors seeking stability and income in the healthcare sector. With a robust market capitalization..

BioNTech SE (BNTX) Stock Analysis: Exploring a 44% Potential Upside Amidst Challenging Metrics

BioNTech SE (NASDAQ: BNTX), a key player in the biotechnology sector, has garnered significant attention from investors seeking opportunities in the healthcare industry. Known for its pioneering mRNA technology, particularly..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 15% Upside with Strong Buy Ratings

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the healthcare sector, commanding a robust market capitalization of $105.51 billion. As a leading operator of medical care facilities..

GSK plc (GSK) Stock Analysis: Evaluating Growth Prospects with a 1.39% Potential Upside

GSK plc (GSK), a prominent player in the healthcare sector, commands attention with its substantial market cap of $113.29 billion. Headquartered in London, this British multinational has carved out a..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Analyzing a Potential 34% Upside with Robust Revenue Growth

Investors have long identified Intuitive Surgical, Inc. (NASDAQ: ISRG) as a pioneer in the healthcare sector, specifically within the realm of medical instruments and supplies. The company’s flagship product, the..

Sanofi (SNY) Stock Analysis: Exploring the 19.74% Potential Upside

Sanofi (NASDAQ: SNY), a healthcare giant headquartered in Paris, France, is a key player in the drug manufacturing industry, particularly known for its comprehensive portfolio that spans immunology, oncology, and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds